Cut: One Woman's Fight Against FGM in Britain Today. By Hibo Wardere

hibo80 From Amazon: ‘Imagine for a moment that you are 6-years-old and you are woken in the early hours, bathed and then dressed in rags before being led down to an ominous looking tent at the end of your garden.

‘And there, you are subjected to the cruellest cut, ordered by your own mother.

‘Forced down on a bed, her legs held apart, Hibo Wardere was made to undergo female genital cutting, a process so brutal, she nearly died.’

Please show this to people you think should read it

Amazon: http://www.amazon.co.uk/s/ref=nb_sb_noss_1?url=search-alias%3Dstripbooks&field-keywords=hibo+wardere

What? Why? Children in Hospital Conference - Preparing Families for Hospital and Improving Health Literacy, May 2016, Edinburgh, UK

hospi80 The conference on Monday 9th May will offer opportunities to discuss how to support anxious children and deal with parental anxiety. Special focus will be on supporting children with a learning disability.

Presentations include:

‘Improving communication to provide person centred care to families.’

Dr Kate McKay, Senior Medical Officer, the Scottish Government

‘Using and promoting psychological strategies to support children and parents who are anxious about hospital.’

Dr Janie Donnan, Consultant Clinical Psychologist.

‘Supporting children with a learning disability in hospital.’

Blair Thomson, Learning Disability Liaison Nurse, NHS Lothian

Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

Visit: www.whatwhychildreninhospital.org.uk

2nd ICPCN Conference: Children’s Palliative Care – NOW! Buenos Aires, Argentina, May 2016

aires80 Building on the success of the first ICPCN conference in Mumbai, India (February 2014), the ICPCN is delighted to bring you the 2nd ICPCN Conference:

Children’s Palliative Care – NOW!

The conference aims to bring together people from around the world and from all professions working with children with life-threatening and life-limiting conditions and encourage the exchange of knowledge, new and innovative ideas, research and experiences between them.

With a line-up of world class keynote and plenary speakers, the conference programme promises to provide rich opportunities for professional development and networking.

Visit: http://www.icpcnconference.org/en/home/

Phase 3 trial is a ‘significant milestone in the development of Epidiolex as a potential new treatment for patients with Dravet syndrome’

From the website of G W Pharmaceuticals: ‘The results of this Epidiolex pivotal trial are important and exciting as they represent the first placebo-controlled evidence to support the safety and efficacy of pharmaceutical cannabidiol in children with Dravet syndrome, one of the most severe and difficult-to-treat types of epilepsy,’ said Orrin Devinsky, M.D., of New York University Langone Medical Center’s Comprehensive Epilepsy Center.

‘These data demonstrate that Epidiolex delivers clinically important reductions in seizure frequency together with an acceptable safety and tolerability profile, providing the epilepsy community with the prospect of an appropriately standardized and tested pharmaceutical formulation of cannabidiol being made available by prescription in the future.’

Learn more here.